Skip to main content
Voxel S.A. logo

Voxel S.A. — Investor Relations & Filings

Ticker · VOX ISIN · PLVOXEL00014 LEI · 2594006D5LHQSL0D5030 WAR Human health and social work activities
Open in API
Filings indexed 862 across all filing types
Latest filing 2023-11-22 Interim / Quarterly Rep…
Country PL Poland
Listing WAR VOX

About Voxel S.A.

https://voxel.pl/

Voxel S.A. is a medical services provider specializing in advanced diagnostic imaging and therapy. The company operates a network of diagnostic centers and laboratories, offering a comprehensive range of services to reimbursed, commercial, and private patients. Its core technological capabilities include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), and single-photon emission computed tomography (SPECT). Through its network, Voxel S.A. focuses on delivering high-quality, accessible diagnostic solutions and related therapeutic services to the healthcare sector.

Recent filings

Filing Released Lang Actions
23 3Q GK Voxel Raport kwartalny
Interim / Quarterly Report Classification · 100% confidence The document is a 'Śródroczny skrócony raport' (Interim Condensed Report) for the Voxel S.A. Capital Group for the 9-month period ending September 30, 2023. It contains detailed financial statements, including consolidated statements of comprehensive income, financial position, cash flows, and changes in equity, along with extensive explanatory notes. This meets the criteria for an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. 9M 2023
2023-11-22 Polish
Transakcja sprzedaży 100% udziałów VITO-MED sp. z o.o. - Content (PL)
M&A Activity Classification · 99% confidence The document text describes a significant corporate transaction involving the establishment of a subsidiary, the transfer of a business unit (Zorganizowana Część Przedsiębiorstwa) via a debt settlement (datio in solutum), and the sale of 100% of the shares in an entity (VM) for 1.00 PLN. This involves capital structure changes, asset transfers, and debt restructuring related to a business operation. This type of announcement, detailing a major transaction like a sale of a business unit or significant asset/share disposal, aligns best with the 'Capital/Financing Update' (CAP) category, as it fundamentally alters the company's structure and financial commitments, or potentially 'Regulatory Filings' (RNS) if it's a mandatory disclosure in Poland. Given the detailed nature of the transaction (sale of shares and settlement of debt), it is a significant corporate action. Since there is no specific category for 'M&A Activity' (TAR) which usually covers takeovers/mergers, and this is a detailed disclosure of a major transaction, 'CAP' (Capital/Financing Update) is the most appropriate fit among the provided options for a significant corporate restructuring/disposal, although 'RNS' is a possibility for general regulatory disclosure. However, the core event is a major transaction impacting capital/financing structure. I will classify it as TAR (M&A Activity) as the sale of 100% of shares in a subsidiary often falls under this umbrella, even if it's structured as a debt settlement combined with a share sale. Re-evaluating the definitions: TAR is for 'merger proposals or takeover bids'. This is a disposal. Since it involves the sale of 100% of shares in an entity, it is a form of divestiture/M&A activity. If TAR is strictly for *proposals* or *bids*, then CAP (Capital/Financing Update) remains strong. Given the complexity and the fact that it's a definitive announcement of a major transaction, I will lean towards TAR as the closest fit for a significant corporate transaction involving share disposal, assuming TAR covers broader M&A events beyond just proposals/bids, or CAP if it's strictly financing. Since the text details the *completion* of a transaction involving the sale of a subsidiary's shares, it is a significant corporate event. Let's check the definitions again. TAR is 'Merger proposals or takeover bids'. This is a sale/divestiture. CAP is 'Updates on company fundraising, financing activities, or capital structure changes'. The sale of a subsidiary and settlement of debt strongly impacts capital structure. I will select CAP as it covers the financing/capital structure change aspect more broadly than the M&A category defined here.
2023-10-31 Polish
23 HY VOXEL RAPORT BR Z PRZEGLĄDU
Audit Report / Information Classification · 99% confidence The document is explicitly titled "RAPORT NIEZALEŻNEGO BIEGŁEGO REWIDENTA Z PRZEGLĄDU ŚRÓDROCZNEGO SKRÓCONEGO SPRAWOZDANIA FINANSOWEGO" (Independent Auditor's Report on the Review of the Interim Condensed Financial Statements) for the period ending June 30, 2023. This document contains the auditor's conclusion based on a review of interim financial statements, which aligns perfectly with the definition of an Audit Report / Information (AR). It is not the full annual report (10-K) nor is it merely an announcement of a report (RPA), as it contains the substantive review conclusion itself. The reference to 'śródrocznego skróconego sprawozdania finansowego' (interim condensed financial statements) confirms it relates to a period shorter than a year, but the document type is the auditor's report on that interim data, not the interim report itself (IR). H1 2023
2023-08-23 Polish
23 HY GK VOXEL RAPORT BR Z PRZEGLĄDU
Audit Report / Information Classification · 98% confidence The document is titled "RAPORT NIEZALEŻNEGO BIEGŁEGO REWIDENTA Z PRZEGLĄDU ŚRÓDROCZNEGO SKRÓCONEGO SKONSOLIDOWANEGO SPRAWOZDANIA FINANSOWEGO" (Independent Auditor's Report on the Review of the Interim Condensed Consolidated Financial Statements) for the period ending June 30, 2023. This explicitly indicates an audit/review report covering interim (half-year) financial data, but it is the report itself, not just an announcement of its publication. The definition for 'Audit Report / Information' (AR) covers standalone audit reports and applied accounting principles. Since this is a review report on interim financials, it fits best under AR, as it is a formal report from an auditor regarding financial statements, distinct from a full Annual Report (10-K) or a simple Earnings Release (ER). The document length (5209 chars) is substantial enough to be the report content rather than just a brief announcement. H1 2023
2023-08-23 Polish
23 HY VOXEL Oświadczenie Zarządu
Regulatory Filings Classification · 95% confidence The document is a formal statement (Oświadczenie) signed by the Management Board of Voxel S.A. confirming that the interim condensed financial statements for the period ending June 30, 2023, were prepared in accordance with accounting standards. Per the 'Certification Rule', documents that are primarily officer certifications or attestations regarding financial reports, rather than the financial reports themselves, should be classified as Regulatory Filings (RNS). H1 2023
2023-08-23 Polish
23 HY GK VOXEL Oświadczenie Zarządu
Regulatory Filings Classification · 95% confidence The document is a formal statement (Oświadczenie) signed by the Management Board of Voxel S.A. confirming that the interim consolidated financial statements for the period ending June 30, 2023, comply with accounting standards. Per the 'Certification Rule', documents that are primarily officer certifications or attestations, even if they reference a specific report type, should be classified as Regulatory Filings (RNS) rather than the report itself, as this document does not contain the actual financial statements. H1 2023
2023-08-23 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.